Leen Al-Alami

Associate | 
T: +1 215 994 2063
F: +1 215 655 2063

Related Publications

  • November 26, 2014 | Dechert OnPoint
  • Winter 2013 | The University of Pennsylvania Journal of Business Law, Vol. 15, No. 2
    Business Roundtable v. SEC: Rising Judicial Mistrust and the Onset of a New Era in Judicial Review of Securities Regulation

Rankings and Recognition

Leen Al-Alami focuses her practice on corporate and securities matters, with particular emphasis on private equity transactions and mergers and acquisitions.

Ms. Al-Alami was a Dechert summer associate in 2012.

Significant Representations

  • Court Square Capital and The Harvard Drug Group, Inc. (“Harvard”), a distributor of generic pharmaceuticals, over-the-counter medications and related products, in the sale of Harvard to Cardinal Health, Inc. (NYSE: CAH) for US$1.15 billion, and in the spinoff of Harvard’s Letco business.
  • Court Square Capital Partners and MacDermid Incorporated, a specialty chemical company, in the US$1.8 billion sale of MacDermid Incorporated to Platform Acquisition Holdings Limited (LSE: PAH).
  • Graham Partners in the sale of Strata Proximity Systems and Strata Products, a global provider of safety products and services in the mining industry, to Wingate Partners.
  • Court Square Capital Partners and NMTI Holdings, Inc., a US technology company and hotel booking services provider, in its US$500 million sale to Amadeus IT Holdings SA, a leading Spanish travel technology company (AMS.MC).
  • Crown Holdings, Inc. (NYSE: CCK) in numerous transactions, including its Rule 144A and Regulation S offerings of €600 million 3.375% senior notes and €650 million 4% senior notes.

Includes matters handled at Dechert or prior to joining the firm.


Harvard University, A.B., 2004, cum laude
Harvard University, A.M., 2004
University of Pennsylvania Law School, J.D., 2013, Associate Editor of the University of Pennsylvania Journal of Business Law

Bar Admissions/Qualifications